"Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool
for analyzing the vast amount of strategic possibilities that have emerged in
the drug development of protein kinase inhibitors (PKIs) for the treatment of
cancer. It is at the same time a map of the research and development, a
history of the achievements up to date, and a guide pointing out the
directions of the future. The product as well, lays the framework of current
treatment strategies and their progress. This tool provides you with an
immense amount of information structured and analyzed to assist you in your
work. It is designed to assist you in finding right partners, optimizing your
licensing deals, wisely choosing which projects give you the best competitive
advantage, and assuring you that your decisions have been based on the most
accurate, validated and precise facts available.
The Package Includes
A progress analysis on current and emerging drugs
Information on most companies active in the development of PKIs in oncology
Information on key industry related PKI drug projects in oncology
Data from most important clinical trials
Information on early developmental stage projects
Possibility of performing advanced searches suited to your individual needs
This Tool will Assist You in:
Tracking cutting edge companies, therapies and new technologies
Rapid identification of partners & competitors
Laying down a comprehensive framework for further analysis of the field
Producing presentations surrounding the development of PKI drugs in
oncology
Identifying emerging PKI cancer products & key areas of pharmaceutical R&D
*This software application is a searchable database reflects the most recent
advances in the field of PKI drug development in cancer, in order to help you
perform your own analysis, go back to the source data for in-depth
information, and present the research and development in tables and graphs
suited for your own specific purposes. A significant advantage with
BioSeeker's software applications is that they provide you with
well-structured information. Each pipeline drug/project has been carefully
defined and classified in categories and subcategories. The main categories
include therapy type, effect, mechanism of action (molecular target),
indication, stage of development etc. These categories are further organized
and classified in sub-categories. In comparison with other available
databases, BioSeeker's software applications give better overview, specific
search capabilities and great dynamic reports.
Analytical Tool - Protein Kinase Inhibitors in Oncology published by BioSeeker Group AB in April 22, 2013. This report price starts from US $ 6674.
The contents of this page may be different from the latest version. Please contact us for details.
